Viatris Inc
NASDAQ:VTRS
Viatris Inc
Short-Term Investments
Viatris Inc
Short-Term Investments Peer Comparison
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Short-Term Investments
$90.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Short-Term Investments
$19B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
18%
|
CAGR 10-Years
7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Short-Term Investments
$340m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-16%
|
|
Pfizer Inc
NYSE:PFE
|
Short-Term Investments
$11.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
Merck & Co Inc
NYSE:MRK
|
Short-Term Investments
$40m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-38%
|
|
Eli Lilly and Co
NYSE:LLY
|
Short-Term Investments
$126.1m
|
CAGR 3-Years
37%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-21%
|
See Also
What is Viatris Inc's Short-Term Investments?
Short-Term Investments
90.8m
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Short-Term Investments amounts to 90.8m USD.
What is Viatris Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
8%
Over the last year, the Short-Term Investments growth was 12%. The average annual Short-Term Investments growth rates for Viatris Inc have been 2% over the past three years , 8% over the past five years .